Skip to main content
. 2021 Jul 9;61(4):1589–1599. doi: 10.1093/rheumatology/keab522

Fig. 2.


Fig. 2

Forest plot of risk of major adverse cardiac events by therapeutic drug class in subgroup analyses

*Not available due to the absence of events in this class. HRw: weighted hazard ratio; CV: cardiovascular.